Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Fuji
Mallinckrodt
Chinese Patent Office
Cantor Fitzgerald
Dow
US Army
McKesson
Baxter

Generated: November 18, 2018

DrugPatentWatch Database Preview

Bracco Company Profile

« Back to Dashboard

What is the competitive landscape for BRACCO, and what generic alternatives to BRACCO drugs are available?

BRACCO has forty-three approved drugs.

There are three US patents protecting BRACCO drugs.

Summary for Bracco
US Patents:3
Tradenames:67
Ingredients:37
NDAs:43
Patent Litigation for Bracco: See patent lawsuits for Bracco

Drugs and US Patents for Bracco

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco CHOLETEC technetium tc-99m mebrofenin kit INJECTABLE;INJECTION 018963-001 Jan 21, 1987 AP RX Yes Yes ➤ Sign Up ➤ Sign Up
Bracco SINOGRAFIN diatrizoate meglumine; iodipamide meglumine SOLUTION;INTRAUTERINE 011324-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up
Bracco CHOLOVUE iodoxamate meglumine INJECTABLE;INJECTION 018077-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Bracco TAGITOL V barium sulfate SUSPENSION;ORAL 208143-005 Aug 4, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up
Bracco CHLORMERODRIN HG 197 chlormerodrin hg-197 INJECTABLE;INJECTION 017269-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Bracco PHOSPHOTEC technetium tc-99m pyrophosphate kit INJECTABLE;INJECTION 017680-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Bracco

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bracco ISOVUE-200 iopamidol INJECTABLE;INJECTION 020327-001 Oct 12, 1994 4,001,323 ➤ Sign Up
Bracco PROHANCE MULTIPACK gadoteridol INJECTABLE;INJECTION 021489-001 Oct 9, 2003 6,143,274 ➤ Sign Up
Bracco MULTIHANCE gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021357-002 Nov 23, 2004 4,916,246 ➤ Sign Up
Bracco PROHANCE gadoteridol INJECTABLE;INJECTION 020131-001 Nov 16, 1992 5,846,519 ➤ Sign Up
Bracco CARDIOGEN-82 rubidium chloride rb-82 INJECTABLE;INJECTION 019414-001 Dec 29, 1989 4,400,358 ➤ Sign Up
Bracco PROHANCE MULTIPACK gadoteridol INJECTABLE;INJECTION 021489-001 Oct 9, 2003 5,846,519 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for Bracco Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB97/081 United Kingdom ➤ Sign Up PRODUCT NAME: GADOBENATE DIMEGLUMINE; REGISTERED: UK 06099/0006 19970722
666 Luxembourg ➤ Sign Up PRODUCT NAME: DASABUVIR OU UN SEL QUI EN DERIVE, Y COMPRIS DASABUVIR SODIUMMONOHYDRATE. FIRST REGISTRATION: 20150119
C0055 France ➤ Sign Up PRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: 434323 20130220
15/074 Ireland ➤ Sign Up PRODUCT NAME: CEFTOLOZANE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR A SULFURIC ACID SALT; REGISTRATION NO/DATE: EU/1/15/1032/001 20150918
595 Luxembourg ➤ Sign Up PRODUCT NAME: SIMEPREVIR, OU L UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES, INCLUANT SIMEPREVIR SODIUM. FIRST REGISTRATION: 20140516
2015 00014 Denmark ➤ Sign Up PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150119
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Queensland Health
Moodys
Federal Trade Commission
Citi
Argus Health
Chinese Patent Office
Farmers Insurance
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.